Seelos Therapeutics Inc (SEEL): www.clinicaltrials.gov/ct2/show/NCT01810...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Seelos Therapeutics Inc (SEEL)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	374
Boards Moderated	0
Alias Born	02/06/2013

Re: None

Monday, 08/12/2013 4:42:14 PM

Monday, August 12, 2013 4:42:14 PM

www.clinicaltrials.gov/ct2/show/NCT01810575?term=alprox+td&rank=19

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

This study has been terminated.
(Re-assessment of study)
Sponsor:
Warner Chilcott

ClinicalTrials.gov Identifier:
NCT01810575
First received: February 27, 2013
Last updated: August 5, 2013
Last verified: August 2013

Vitaros trial has been terminated by Warner Chilcott?

What does this mean?

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SEEL News

Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM

More SEEL News

InvestorsHub NewsWire

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow